Crinetics Pharmaceuticals Inc
Price
FilingsNewest: 8-K, Agreement endedSep 1 →InsidersNo open-market buys. 8 insiders sold $6.5M, all 18 sales on a 10b5-1 plan.→HoldersFMR 15.0%BlackRock 9.2%Farallon 8.5%→PeersClosest companies: TYRA, BDTX, TNGX→
From the filings
Figures
- Revenue
- $42.2Mlast 12 months
- Net income
- −$501.6Mlast 12 months
- Operating cash flow
- −$422.5Mlast 12 months
- Cash and equivalents
- $55.5Mat the last balance sheet
- Shares outstanding
- 105.8M shareson issue